Massachusetts Financial Services’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$321K Sell
3,232
-84
-3% -$11K ﹤0.01% 913
2025
Q4
$403K Buy
+3,316
New +$416K ﹤0.01% 883
2020
Q2
Sell
-257,874
Closed -$3.12M 843
2020
Q1
$3.12M Sell
257,874
-110,252
-30% -$1.85M ﹤0.01% 649
2019
Q4
$7M Buy
368,126
+113
+0% +$2.08K ﹤0.01% 626
2019
Q3
$8.74M Sell
368,013
-1,374
-0.4% -$33K ﹤0.01% 620
2019
Q2
$10.7M Buy
+369,387
New +$10.1M ﹤0.01% 617

Other funds holding TMDX

Massachusetts Financial Services's TMDX Position: Q1 2026 in Review

Massachusetts Financial Services reduced its Transmedics (TMDX) stake by 2.5% in Q1 2026, selling an estimated $11K and leaving 3,232 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #913.

Massachusetts Financial Services first reported a position in TMDX in Q2 2019 and has held it in 6 quarters since. The position peaked at $10.7M in Q2 2019. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Massachusetts Financial Services held 3,232 shares of Transmedics worth $321K as of Q1 2026.
  • Massachusetts Financial Services sold 84 Transmedics shares in Q1 2026, an estimated $11K.
  • Transmedics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q1 2026, its #913 holding.
  • Massachusetts Financial Services first reported a position in Transmedics in Q2 2019 and has held it in 6 quarters since.
  • Massachusetts Financial Services's Transmedics position peaked at $10.7M in Q2 2019.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.